is urging hospitals to remain highly vigilant in managing their blood inventories, especially type O negative red blood cells and AB plasma, as these products are in short supply this summer. AABB recommends hospitals reserve AB plasma for blood group AB patients with definitive transfusion needs. For situations where type O negative red blood cells and AB plasma are used as part of a massive transfusion protocol for patients of unknown blood type, every effort should be made to obtain a blood type for the patient as soon as possible. “Maintaining a safe and adequate blood supply is critical to the nation’s public health and a priority for the medical community,” said Miriam A. Markowitz, CEO of AABB. Hospitals are urged to follow available clinical practice guidelines for the appropriate use of individual blood products. AHA and AABB collaborated on a  to assist hospitals as they implement a patient blood management approach as a component of their care planning decisions. 

Related News Articles

Headline
The House Energy and Commerce Committee May 13 began to mark up its portion of the fiscal year 2025 reconciliation bill. The committee has been instructed to…
Headline
The House Ways and Means Committee May 13 began to mark up its portion of the fiscal year 2025 reconciliation bill, with some proposals impacting the health…
Headline
The Centers for Medicare & Medicaid Services May 12 issued a proposed regulation that would change how states may structure provider taxes for purposes of…
Headline
The Centers for Medicare & Medicaid Services and the Assistant Secretary for Technology Policy/Office of the National Coordinator for Health Information…
Headline
The Department of Health and Human Services May 13 announced a 60-day public comment period opened for stakeholders regarding its request for information to…
Headline
The Coalition to Strengthen America’s Healthcare May 13 released a new 30-second television and digital advertisement about a family considering whether it can…